Replies to post #204873 on Biotech Values

[north40000]

Interesting stock returns in phantom portfolios since April 1...and October 10 ESMO presentation + Dr. Wolchok's MSK lab reports in early November have not happened yet.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125517991

[vinmantoo]

PPHM—A tenfold gain in the share price (what you posited) based on post-hoc biomarker data from a trial that was halted for futility would be an astonishing development. The colossal cash ball from outer space (#msg-125278503) is more likely, IMO.

I would go with the cash ball meteor too.

[swampboots]

This fact is unassailable:
There are no failed drugs, only imprecise ways of testing them in all the infinite combinations and environments.

And there lies the wiggle room for statement which have enormous stupidity.

[DewDiligence]

PPHM still p-hacking SUNRISE data:

https://globenewswire.com/news-release/2017/06/05/1008110/0/en/Peregrine-Pharmaceuticals-Presents-Preliminary-Correlative-Analysis-of-PD-L1-Expression-from-SUNRISE-Trial-at-ASCO-2017.html